Patient-Funded Trials: Opportunity or Liability?

Patient-funded trials (PFTs) are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of pati...

Full description

Saved in:
Bibliographic Details
Published in:Cell stem cell 2015-08, Vol.17 (2), p.135-137
Main Authors: Wenner, Danielle Marie, Kimmelman, Jonathan, London, Alex John
Format: Article
Language:English
Subjects:
Clinical Trials as Topic - economics
Goals
Humans
Motivation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patient-funded trials (PFTs) are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols.
ISSN:1934-5909
1875-9777
DOI:10.1016/j.stem.2015.07.016